Health Condition 1: N186- End stage renal disease Health Condition 2: Z00-Z99- Factors influencing health status and contact with health services
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patient on dialysis > 2 times per week with mature upper extremity AVF/ AVG in use for 1 month or more which is able to provide flow rates of > 250 ml/min sustained for a period of 4 weeks or more. 2) Tunnel catheter with good flows for 2 weeks can be included 3) No access flow issues prior to inclusion in study (flow rates of 250ml / minutes and above can be achieved consistently for a period of 4 weeks) and patients with prior history of AV access angiography or angioplasty with functional AV access (post intervention flow rates of > 250 ml/min sustained for a period of 4 weeks or more) 4) Adult population between ages of 18-65 years will be included in study
Exclusion criteria
Exclusion criteria: 1)Patients with documented procoagulant state. 2)Patients with more than 2 primary access failures 3)Inability to provide consent 4)Patient of acute kidney injury and patients planned for transplant in next 6 months 5)Patients of congestive heart failure (defined as EF 6)Patients needing more than standard dose of Heparin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To develop a low cost, efficient system for Vascular Access Surveillance for developing countriesTimepoint: Baseline and quarterly four visits | — |
Secondary
| Measure | Time frame |
|---|---|
| To study the efficacy of VAS system in detecting AVF and AVG dysfunction Timepoint: Baseline and quarterly four visits | — |
Countries
India
Contacts
Indraprastha Apollo Hospital